This study is a three-group randomized, prospective trial. HIV-infected patients admitted for in-patient care who report having recently used opioids and/or stimulants and/or heavy alcohol in the past 12 months are eligible. Patients will be randomized to one of the following three groups: 1) Patient Navigator intervention, 2) Patient Navigator plus Contingency Management intervention, and 3) Treatment as Usual.
Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.